SPIE Life Science Engineering GmbH is a German engineering firm specializing in services for the pharmaceutical, biotechnology, chemistry, and medical devices sectors. Headquartered in Nuremberg, the company delivers engineering, planning, project management, and EPCMV solutions in GMP environments. It was formerly known as Otto Life Science Engineering GmbH and became part of the SPIE group following an acquisition completed in 2024. In July 2026, SPIE acquired nimeg ag, a Swiss engineering provider based in Baden-Dättwil, to expand its life sciences offerings and strengthen its position as a general contractor for integrated projects in Switzerland.
Also known as Otto Life Science Engineering GmbH.
None yet. When a new project in the record names SPIE Life Science Engineering GmbH as owner, partner or investor, it shows here.
Strengthens Swiss GMP/EPCMV engineering capability to deliver EPC projects as general contractor for pharma, biotech and medical‑device clients; nimeg reported ~€5m revenue in 2025.
